Can Citalopram Cause Amenorrhea?
Citalopram can cause amenorrhea, though this is not a commonly recognized adverse effect in FDA labeling, and the mechanism likely involves indirect pathways rather than direct hormonal disruption.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for citalopram lists dysmenorrhea (painful menstruation) in 3% of female patients versus 2% in placebo, but amenorrhea is not specifically listed as a recognized adverse effect in the comprehensive adverse event tables from controlled trials 1. The label documents "heavy menstrual periods" as a potential side effect in children and adolescents, but again, amenorrhea is not explicitly mentioned 1.
Clinical Case Evidence
Despite the absence in FDA labeling, a published case report documents escitalopram (the active S-enantiomer of citalopram) causing amenorrhea in a 34-year-old woman with major depressive disorder, suggesting this is a real but underreported phenomenon 2. This case emphasizes that women of childbearing age should be carefully monitored for amenorrhea while on SSRI treatment 2.
Broader SSRI Class Evidence
A large cross-sectional study of 1,432 women found that menstrual disorders occurred in 24.6% of women taking antidepressants versus 12.2% of controls, with an antidepressant-induced menstruation disorder incidence of 14.5% 3. While paroxetine, venlafaxine, and sertraline were most strongly associated with menstrual disorders in this study, the overall incidence was similar across SSRIs, suggesting a class effect that would include citalopram 3.
Proposed Mechanisms
Indirect Stress-Hormone Pathway
SSRIs like citalopram may affect menstruation through modulation of the stress response system rather than direct hormonal effects 4. Research in primates demonstrates that:
- Citalopram decreases corticotropin-releasing factor (CRF) fiber density in the dorsal raphe and increases CRF-R2 receptor expression 4
- CRF directly suppresses GnRH pulse secretion from the hypothalamus, which is the primary mechanism underlying functional hypothalamic amenorrhea 5, 6
- Kisspeptin neurons serve as the critical bridge between stress response systems and the reproductive axis, mediating stress effects on menstruation 5, 6
Functional Hypothalamic Amenorrhea Connection
Chronic stress causes functional reduction in pulsatile GnRH secretion, decreasing LH and FSH pulses, which prevents ovulation and causes amenorrhea 5. Since depression itself is a significant stressor and SSRIs modulate stress pathways, the relationship between citalopram and amenorrhea may be bidirectional—the underlying psychiatric condition contributes to menstrual dysfunction, while the medication may either help or hinder depending on individual stress-hormone dynamics 4, 7.
Clinical Implications and Monitoring
When to Suspect SSRI-Related Amenorrhea
Consider citalopram as a potential contributor to amenorrhea when:
- Amenorrhea develops temporally after SSRI initiation 2
- Other causes of secondary amenorrhea have been excluded (pregnancy, PCOS, thyroid dysfunction, hyperprolactinemia, primary ovarian insufficiency) 5
- The patient does not have significant weight changes or excessive exercise that would explain functional hypothalamic amenorrhea 5, 7
Essential Workup
When amenorrhea occurs in a patient taking citalopram, evaluate:
- Pregnancy test (noting that false-positive urine pregnancy tests have been reported with escitalopram) 2
- TSH and prolactin levels to exclude thyroid dysfunction and hyperprolactinemia 5
- FSH and LH levels: elevated suggests primary ovarian insufficiency; low suggests hypothalamic amenorrhea 5
- Assessment for PCOS: LH:FSH ratio >2, hyperandrogenism, polycystic ovarian morphology 5
Critical Diagnostic Pitfall
Approximately 40-47% of women with functional hypothalamic amenorrhea have polycystic ovarian morphology (AHF-PCOM), which can be misdiagnosed as PCOS 5. This distinction is critical because AHF-PCOM requires correction of energy deficit and stress reduction as primary treatment, not PCOS-targeted therapy 5.
Management Approach
First-Line Strategy
If amenorrhea develops on citalopram and other causes are excluded, consider:
- Addressing underlying stressors (psychological stress, inadequate nutrition, excessive exercise) as these are the primary drivers of functional hypothalamic amenorrhea 5, 7
- Monitoring for at least 3-6 months while optimizing lifestyle factors before attributing amenorrhea solely to medication 7
- Evaluating whether the antidepressant benefit outweighs the menstrual dysfunction, as untreated depression itself can cause amenorrhea through stress-hormone pathways 5, 6
When to Consider Medication Change
Switch from citalopram to an alternative antidepressant if:
- Amenorrhea persists beyond 6 months despite lifestyle optimization 5
- The patient desires fertility and amenorrhea is clearly medication-related 2
- Bone health becomes a concern, as prolonged hypoestrogenism from amenorrhea increases fracture risk and requires DXA scanning 5
Bone Health Monitoring
The American College of Sports Medicine recommends DXA scanning if amenorrhea extends beyond 6 months, regardless of age, due to accelerated bone loss from hypoestrogenism 5. This applies to SSRI-associated amenorrhea just as it does to other causes of functional hypothalamic amenorrhea.
Important Caveats
The relationship between citalopram and amenorrhea is likely underreported because patients and physicians may be reluctant to discuss menstrual changes, similar to sexual dysfunction with SSRIs 1. The FDA label acknowledges that "reliable estimates of the incidence and severity of untoward experiences involving sexual desire, performance, and satisfaction are difficult to obtain" 1, and the same limitation applies to menstrual disorders.
Weight changes associated with antidepressants can indirectly trigger PCOS in predisposed women, leading to oligomenorrhea or amenorrhea 8, 9. However, citalopram is generally weight-neutral (mean weight loss of 0.5 kg in trials) 1, making this mechanism less likely than with other psychotropic medications.